Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: Resverlogix Provides Unrestricted Educational Grant for Epigenetic Symposium at International Renal Congress
The "Epigenetics in CKD & CVD: A potential breakthrough therapy?" symposium concluded a couple of hours ago, and the Friday May 25th poster session will conclude shortly. The other poster is tomorrow. Good luck in Denmark! Hopefully apabetalone and BET bromodomains are getting the attention of the ERA-EDTA folk and promoting some good discussion.
